This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Title: John Haynes Weis: Innovator in Herpes Simplex Viral Proteins
Introduction
John Haynes Weis is an inventor based in the United States, known for his contributions to the field of molecular genetics. He has focused on the cloning and expression of Herpes Simplex Virus (HSV) glycoprotein genes, which are crucial for developing vaccines against HSV infections.
Latest Patents
John Haynes Weis holds 0 patents. However, his work on the production of herpes simplex viral proteins has significant implications for vaccine development. The methods and compositions he has developed involve the cloning and expression of HSV type 1 and type 2 glycoprotein genes in single-cell host organisms.
Career Highlights
Weis has been associated with Molecular Genetics, Inc., where he has worked on innovative techniques to produce HSV-gene products. His research aims to formulate HSV gD-related polypeptides as immunogens for vaccines, providing protection against HSV-1 and HSV-2 infections.
Collaborations
Throughout his career, John Haynes Weis has collaborated with notable colleagues, including Roger John Watson and Lynn William Enquist. Their combined expertise has contributed to advancements in the field of molecular genetics and vaccine development.
Conclusion
John Haynes Weis has made significant strides in the field of herpes simplex viral proteins, focusing on innovative methods for vaccine development. His work continues to influence the landscape of immunology and genetic research.